Breast Cancer Clinical Trials in New York

Showing 621-640 of 652 trials

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

NCT00817362

The purpose of this study is to see if IPI-504 in combination with trastuzamab is an effective treatment in HER2 positive metastatic breast cancer

Breast CancerHER2 Positive Breast CancerMetastatic Breast Cancer+1 more

Infinity Pharmaceuticals, Inc.29 participantsStarted Mar 2009

Palm Springs, California, United States • Boca Raton, Florida, United States • Davie, Florida, United States +8 more locations

COMPLETEDPhase 3< 1 mile

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

NCT00002920

RATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen. PURPOSE: Randomized phase III trial to study the effectiveness of medroxyprogesterone in preventing endometrial disorder in postmenopausal women who have ductal carcinoma in situ, lobular carcinoma in situ, Paget's disease of the nipple, stage I breast cancer, or stage II breast cancer and who are taking tamoxifen.

Breast CancerEndometrial Cancer

SWOG Cancer Research Network313 participantsStarted Mar 1997

Mobile, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +119 more locations

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Breast Cancer Trials in Other Cities

CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study

Pain in Cancer Survivors

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

A Survey of Sleep Problems in Survivors of Breast Cancer

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer

A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer

Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

Docetaxel in Node Positive Adjuvant Breast Cancer

Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

Xpress Digital Mammography System Images for Computer Aided Detection Development

Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

Other Conditions in New York